134 related articles for article (PubMed ID: 38903719)
1. A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review.
Yin C; Liu ZJ; He C; Yu HX
Front Oncol; 2024; 14():1399868. PubMed ID: 38903719
[TBL] [Abstract][Full Text] [Related]
2. [Thoracic
Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
[TBL] [Abstract][Full Text] [Related]
3. Thoracic SMARCA4-deficient undifferentiated tumor.
Jiang J; Chen Z; Gong J; Han N; Lu H
Discov Oncol; 2023 Apr; 14(1):51. PubMed ID: 37115343
[TBL] [Abstract][Full Text] [Related]
4. Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.
Lin Y; Yu B; Sun H; Zhang H; Hu Z; Zhang Y; Wu Z; Sun S; Zhao X; Yu H; Wu X; Li Y; Wang J; Wang H
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8663-8671. PubMed ID: 37115272
[TBL] [Abstract][Full Text] [Related]
5. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract][Full Text] [Related]
6. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
PeerJ; 2024; 12():e16923. PubMed ID: 38374950
[TBL] [Abstract][Full Text] [Related]
7. Thoracic SMARCA4-deficient undifferentiated tumor-a case of an aggressive neoplasm-case report.
Roden AC
Mediastinum; 2021; 5():39. PubMed ID: 35118344
[TBL] [Abstract][Full Text] [Related]
8. Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.
Iwakoshi A; Sasaki E; Sato M; Sugiyama K; Kogure Y; Kitagawa C; Nishimura R
Am J Surg Pathol; 2022 Jul; 46(7):1000-1006. PubMed ID: 35220352
[TBL] [Abstract][Full Text] [Related]
9. Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report.
Kunimasa K; Okami J; Takenaka S; Honma K; Kukita Y; Nagata S; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Tahara H; Kumagai T
JTO Clin Res Rep; 2021 Nov; 2(11):100235. PubMed ID: 34746887
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report.
Yang P; Xiong F; Lin Y; Liang P; Tang C
Transl Cancer Res; 2023 Apr; 12(4):1041-1048. PubMed ID: 37180644
[TBL] [Abstract][Full Text] [Related]
11. Thoracic SMARCA4-Deficient Undifferentiated Tumors With Unusual Presentations: A Case Series.
Helmink AJ; Alshomrani A; Lauer SR; Yuil-Valdes A
Int J Surg Pathol; 2023 Oct; ():10668969231206350. PubMed ID: 37903457
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
[TBL] [Abstract][Full Text] [Related]
13. Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases.
Zhou P; Fu Y; Wang W; Tang Y; Jiang L
Orphanet J Rare Dis; 2024 Jun; 19(1):237. PubMed ID: 38877473
[TBL] [Abstract][Full Text] [Related]
14. Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review.
Yang D; Wang Y
Transl Lung Cancer Res; 2024 Feb; 13(2):443-452. PubMed ID: 38496696
[TBL] [Abstract][Full Text] [Related]
15. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
Mundada M; Mannan KA; Vasu D; Ahmed F; K S
Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
[TBL] [Abstract][Full Text] [Related]
16. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
[TBL] [Abstract][Full Text] [Related]
17. Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
Gantzer J; Davidson G; Vokshi B; Weingertner N; Bougoüin A; Moreira M; Lindner V; Lacroix G; Mascaux C; Chenard MP; Bertucci F; Davidson I; Kurtz JE; Sautès-Fridman C; Fridman WH; Malouf GG
Oncologist; 2022 Jun; 27(6):501-511. PubMed ID: 35278076
[TBL] [Abstract][Full Text] [Related]
18. Thoracic SMARCA4-deficient undifferentiated tumor with associated granulomatous reaction and response to pembrolizumab.
Marshall M; Khader S; Beasley S; Lajara S
Diagn Cytopathol; 2023 Oct; 51(10):E287-E293. PubMed ID: 37350425
[TBL] [Abstract][Full Text] [Related]
19. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
Nambirajan A; Jain D
Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
[Next] [New Search]